D058831Chemicals & DrugsD27.505.519.625.850.850.300D27.505.696.577.850.850.3004180.978491Serotonin 5-HT3 Receptor Antagonistsprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonNeurobiology29796708Chow R, Warr DG, Navari RM, Tsao M, Popovic M, Chiu L, Milakovic M, Lam H, DeAngelis CSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerShould palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis. Support Care Cancer. 2018 Aug; 26(8):2519-2549.Support Care Cancer2018-05-23T00:00:002018Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis.31324772Basak S, Gicheru Y, Kapoor A, Mayer ML, Filizola M, Chakrapani SNature communicationsMolecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor. Nat Commun. 2019 07 19; 10(1):3225.Nat Commun2019-07-19T00:00:002019Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor.3.314540.01851554research area of0.7223310.05936719subject area forFamily MedicineUniversity of ChicagoSudhaChakrapaniSudha Chakrapani41.78927490000000-87.601250000000001126Chakrapani, SudhaRudolphNavariRudolph Navari41.78927490000000-87.601250000000001347Navari, RudolphChristopher O.OlopadeChristopher O. Olopade41.78927490000000-87.601250000000001604Olopade, Christopher O.ProfessorWilliamGreenWilliam Green41.78927490000000-87.60125000000000303Green, WilliamProfessortrue1true1true1ProfessorProfessortrue1ProfessorProfessor25323946Navari RMExpert opinion on pharmacotherapyPalonosetron for the treatment of chemotherapy-induced nausea and vomiting. Expert Opin Pharmacother. 2014 Dec; 15(17):2599-608.Expert Opin Pharmacother2014-10-17T00:00:002014Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.25838122Navari RMBiochimica et biophysica acta5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy. Biochim Biophys Acta. 2015 Oct; 1848(10 Pt B):2738-46.Biochim Biophys Acta2015-03-30T00:00:0020155-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.27050207Navari RM, Aapro MThe New England journal of medicineAntiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting. N Engl J Med. 2016 Apr 07; 374(14):1356-67.N Engl J Med2016-04-07T00:00:002016Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.